Genomatica to develop processes for bio-based nylon intermediates

05 August 2014 17:26 Source:ICIS News

HOUSTON (ICIS)--Genomatica on Tuesday announced a programme to develop process technologies for the bio-based production of nylon intermediates, including hexamethylenediamine (HMD), caprolactam and adipic acid (ADA).

The US developer of bio-based processes said that the three intermediates have a total market of more than $18bn/year.

Genomatica’s processes for nylon intermediates would be aimed at providing on-purpose alternatives to current processes while avoiding the price volatility or limited supply sources of current raw materials such as benzene or adiponitrile, it said.

Genomatica expects that the development of commercial processes for nylon intermediates will take several years, it added.

Nylon intermediates will be a third major platform for Genomatica, along with its already commercialised GENO BDO process for bio-butanediol (BDO) and another programme for bio-based butadiene (BD).

By Stefan Baumgarten